Cornucopian Capital is a venture capital firm investing in Medicine 3.0 companies across healthspan, performance, longevity, personalized care, bioactives, therapeutics, biomarker measurement and supporting infrastructure. The firm backs pre-Seed through Series B+ companies in the United States, has acted as a lead investor, and targets initial checks of $250,000 to $5M. Sector exposure spans HealthTech, wellness, life sciences, biotechnology, pharmaceuticals, nutrition, medical devices, AI, data and SaaS.